Nurix Therapeutics, Inc.NRIXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+84.3%
5Y CAGR+78.7%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+84.3%/yr
vs +43.9%/yr prior
5Y CAGR
+78.7%/yr
Recent acceleration
Acceleration
+40.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
18.2x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $21.97M | +11.4% |
| 2024 | $19.73M | +77.5% |
| 2023 | $11.12M | +216.9% |
| 2022 | $3.51M | +326.1% |
| 2021 | $823000.00 | -31.8% |
| 2020 | $1.21M | +55.4% |
| 2019 | $776000.00 | -5.1% |
| 2018 | $818000.00 | - |